Correlation of frailty assessment metrics in one-year follow-up of aged care residents: a sub-study of a randomised controlled trial.

Publication Year: 2023

DOI:
10.1007/s40520-023-02491-y

PMCID:
PMC10520153

PMID:
37452224

Journal Information

Full Title: Aging Clin Exp Res

Abbreviation: Aging Clin Exp Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Geriatrics

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Conflict of interestRB was employed as the ReMInDAR partnership engagement and trial manager to oversee the operations management for the trial. No other conflict of interests to declare. Ethics approval and consent to participateEthics approvals have been obtained from the Human Research Ethics Committee of [blinded for review] (ID: 0000036440) and [blinded for review] (ID: H0017022). The trial adopted an “opt out approach”, and all methods were carried out in accordance with relevant guidelines and regulations. This approach was requested by the participating aged care homes, as the requirement for explicit consent would compromise the necessary level of participation. The “opt out approach” was approved by both ethics committees based on low risk carried by the trial, significant public interest and provision of information to residents and opportunity to withdraw. Written informed consent was obtained separately from participants to access to their Medicare Benefits Schedule (MBS), Pharmaceutical Benefits Scheme (PBS) and state hospital data through the respective data custodians. Consent for publicationNot applicable. Conflict of interest RB was employed as the ReMInDAR partnership engagement and trial manager to oversee the operations management for the trial. No other conflict of interests to declare."

Evidence found in paper:

"Funding Open Access funding enabled and organized by CAUL and its Member Institutions. This work was supported by the Australian Government Department of Health Pharmacy Trial Program. The Australian Government Department of Health reviewed the manuscript before submission but played no role in the study design, data collection, management, writing of manuscript or decision to submit the paper for publication."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025